Literature DB >> 22367968

High levels of somatic DNA diversity at the myotonic dystrophy type 1 locus are driven by ultra-frequent expansion and contraction mutations.

Catherine F Higham1, Fernando Morales, Christina A Cobbold, Daniel T Haydon, Darren G Monckton.   

Abstract

Several human genetic diseases are associated with inheriting an abnormally large unstable DNA simple sequence repeat. These sequences mutate, by changing the number of repeats, many times during the lifetime of those affected, with a bias towards expansion. These somatic changes lead not only to the presence of cells with different numbers of repeats in the same tissue, but also produce increasingly longer repeats, contributing towards the progressive nature of the symptoms. Modelling the progression of repeat length throughout the lifetime of individuals has potential for improving prognostic information as well as providing a deeper understanding of the underlying biological process. A large data set comprising blood DNA samples from individuals with one such disease, myotonic dystrophy type 1, provides an opportunity to parameterize a mathematical model for repeat length evolution that we can use to infer biological parameters of interest. We developed new mathematical models by modifying a proposed stochastic birth process to incorporate possible contraction. A hierarchical Bayesian approach was used as the basis for inference, and we estimated the distribution of mutation rates in the population. We used model comparison analysis to reveal, for the first time, that the expansion bias observed in the distributions of repeat lengths is likely to be the cumulative effect of many expansion and contraction events. We predict that mutation events can occur as frequently as every other day, which matches the timing of regular cell activities such as DNA repair and transcription but not DNA replication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367968     DOI: 10.1093/hmg/dds059

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

Review 1.  Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models.

Authors:  Vanessa C Wheeler; Vincent Dion
Journal:  J Huntingtons Dis       Date:  2021

2.  MSH3 Promotes Dynamic Behavior of Trinucleotide Repeat Tracts In Vivo.

Authors:  Gregory M Williams; Jennifer A Surtees
Journal:  Genetics       Date:  2015-05-11       Impact factor: 4.562

3.  Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.

Authors:  Fernando Morales; Eyleen Corrales; Baili Zhang; Melissa Vásquez; Carolina Santamaría-Ulloa; Hazel Quesada; Mario Sirito; Marcos R Estecio; Darren G Monckton; Ralf Krahe
Journal:  Hum Mol Genet       Date:  2021-12-27       Impact factor: 5.121

4.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

5.  Parental age effects, but no evidence for an intrauterine effect in the transmission of myotonic dystrophy type 1.

Authors:  Fernando Morales; Melissa Vásquez; Patricia Cuenca; Domingo Campos; Carolina Santamaría; Gerardo Del Valle; Roberto Brian; Mauricio Sittenfeld; Darren G Monckton
Journal:  Eur J Hum Genet       Date:  2014-07-23       Impact factor: 4.246

6.  Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutLα endonuclease activation.

Authors:  Anna Pluciennik; Vickers Burdett; Celia Baitinger; Ravi R Iyer; Kevin Shi; Paul Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

7.  De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.

Authors:  Sarah A Cumming; Mark J Hamilton; Yvonne Robb; Helen Gregory; Catherine McWilliam; Anneli Cooper; Berit Adam; Josephine McGhie; Graham Hamilton; Pawel Herzyk; Michael R Tschannen; Elizabeth Worthey; Richard Petty; Bob Ballantyne; Jon Warner; Maria Elena Farrugia; Cheryl Longman; Darren G Monckton
Journal:  Eur J Hum Genet       Date:  2018-07-02       Impact factor: 4.246

8.  Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.

Authors:  Baziel van Engelen
Journal:  Trials       Date:  2015-05-23       Impact factor: 2.279

Review 9.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

10.  Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.

Authors:  Andrie Koutsoulidou; Tassos C Kyriakides; George K Papadimas; Yiolanda Christou; Evangelia Kararizou; Eleni Zamba Papanicolaou; Leonidas A Phylactou
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.